Belight3™ | Award-Winning Innovation in Anti-Dark Spot Solutions

Belight3™: Award-Winning Innovation in Anti-Dark Spot Solutions

Beauty is no longer defined solely by flawless skin or a captivating smile - it now embodies confidence, holistic well-being, and a radiant glow from within. This holistic view is fuelling the rise of nutricosmetics and beauty supplements.

In 2023, these products claimed the largest share of the retail market, reflecting growing consumer demand for solutions that address age-related concerns and enhance skin health from the inside out. This upward trend is further driven by a strong preference for natural and organic ingredients, especially botanicals, which play a key role in revenue growth.

---

Introducing Belight3™: Your Anti-Dark Spot Ritual from France

 In this flourishing era of "beauty from within," we are thrilled to introduce you to Belight3™, a patented oral nutricosmetic solution designed to reduce age- and sun-related hyperpigmentation and dark spots, promoting a naturally radiant and even skin tone. It is composed of four powerful ingredients that work synergistically to brighten the skin complexion:

• Grape seed polyphenols

• Grape viniferin

• Licorice extract

• Vitamin C

This synergistic blend offers triple action benefits: regulate tyrosinase activity, prevent UV-induced melanin synthesis, and deliver antioxidant protection. Belight3™ targets melanin production at its source, inhibiting tyrosinase activity by up to 85%. Clinically validated through two gold-standard studies - first on Asian skin, then on Caucasian skin, Belight3™ boasts high consumer satisfaction, reinforcing its strong competitive edge in the rapidly expanding beauty and wellness market. Its innovation has even positioned it as the winner for Ingredient of the Year – Beauty from Within at the NutraIngredients Awards Europe 2025.

What the judges said:

“Belight³™ stood out for its thoughtful use of a natural, upcycled ingredient, supported by strong scientific validation. The judges appreciated how it effectively responds to the increasing consumer demand for solutions targeting hyperpigmentation. This innovation reflects a commendable alignment of sustainability, science, and market relevance.”

---

Synergistic Action To Regulate Melanin Synthesis

-85% Inhibition of Tyrosinase Activity

(Image credit: Belight3™ - Proprietary In Vitro Evidence)

The Clinically Proven Oral Anti-Dark Spot Formula

Proprietary Clinical Study on Asian Skin

A randomized, double-blind, placebo-controlled trial was conducted on 58 healthy Asian participants (aged 45 - 65) with visible facial dark spots and skin phototypes III to IV. After 12 weeks of daily supplementation with 300 mg of Belight3™, the results showed a significant improvement in skin complexion (-24.5%) and a marked reduction in dark spots (-76.8%).

(Image credit: Belight3™ - Proprietary Clinical Study on Asian Skin)

Proprietary Clinical Study on Caucasian Skin

A randomized, double-blind, placebo-controlled trial was conducted on 66 male and female participants with skin phototypes I to III, all exhibiting hyperpigmentation. After 12 weeks of daily supplementation with 300mg of Belight3™, the study demonstrated a progressive lightening of facial dark spots (-22.4%) and improved overall skin tone evenness (72%).

(Image credit: Belight3™ - Proprietary Clinical Study on Caucasian Skin)

Embrace the Belight3™ Difference

With Belight3™, you're not just taking a supplement; you’re embracing a science-backed, plant-based anti-dark spot ritual that helps your skin radiate its natural beauty. Say goodbye to the frustration of uneven skin tone and welcome a brighter, more confident you. Stay tuned to discover more benefits of Belight3™ and how it can enhance your daily beauty routine.

Find Out More

---

Based in Bordeaux (France), Activ'Inside is a health food-tech company specialized in the development, production, and marketing of nutraceutical active ingredients and botanical extracts supported by clinically proven efficacy and scientifically validated claims.